The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC

Clinical trial NCT04929080 · COMPLETED

Trial details

NCT number: NCT04929080
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinom Nasopharyngeal Carcinoma

Start date: 2021-05-11
Primary completion: 2023-03-06
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.